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Depressive symptoms are associated with soluble P-selectin
reactivity to acute exercise in heart failure
Abstract
BACKGROUND: To determine the effects of depressive symptom severity on the circulating soluble
adhesion molecule response to an acute exercise challenge in patients with heart failure (HF) compared
with control subjects. METHODS: Thirty-eight male HF patients and 19 male control subjects (mean
age +/- SEM: 55.5 +/- 1.9) completed the Beck Depression Inventory (BDI) before undergoing a
moderate 20-minute bicycle exercise at approximately 65% to 70% VO(2peak). Plasma levels of the
soluble adhesion molecules P-selectin (sP-selectin) (sCD62P) and soluble intercellular adhesion
molecule-1 (sICAM-1) were determined immediately before and after and 10 minutes after exercise.
RESULTS: Higher BDI scores moderated greater increases in sP-selectin levels in response to exercise
over time in HF patients as compared with control subjects [F(1.8/84.5) = 3.25, p = .05]. Post hoc
testing revealed that in HF patients, but not in control subjects, higher BDI scores were significantly
associated with greater increases in sP-selectin levels over time in response to exercise [BDI by exercise
interaction: F(1.6/49.6) = 5.67, p = .010]. Also, in HF patients, but not in control subjects, higher BDI
scores were associated with higher sP-selectin levels at pre-exercise and postexercise time points [main
effect BDI: F(1/31) = 4.86, p = .035]. CONCLUSIONS: Our findings suggest that in male HF patients
with increasing depressive symptom severity, levels of the adhesion molecule sP-selectin are higher
before and after exercise and have greater increases in response to exercise. This could have
implications for acute coronary syndromes associated with exercise and thereby may impact mortality.
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Background: To determine the effects of depressive symptom severity on the 
circulating soluble adhesion molecule response to an acute exercise challenge in patients with 
heart failure (HF) compared to controls.    
Methods: 38 male HF patients and 19 male controls (mean age ± SEM: 55.5 ± 1.9) 
completed the Beck Depression Inventory (BDI) before undergoing a moderate 20-min 
bicycle exercise at approximately 65-70% VO2peak. Plasma levels of the soluble adhesion 
molecules sP-selectin (sCD62P) and ICAM-1 (sICAM-1) (ELISA) were determined 
immediately before and after, and 10 min after exercise.    
Results: Higher BDI scores moderated greater increases in sP-selectin levels in 
response to exercise over time in HF patients as compared to controls (F(1.8/84.5) = 3.25, p 
= .05 ,η p 2 = .06). Post-hoc testing revealed that in HF patients, but not in controls, higher 
BDI scores were significantly associated with greater increases in sP-selectin levels over time 




Also, in HF patients, but not in controls, higher BDI scores were associated with higher sP-
selectin levels at pre and post-exercise time points (main effect BDI: F(1/31) = 4.86, p= .035, 
η p 2 = .14). Conclusions: Our findings suggest that in male HF patients with increasing 
depressive symptom severity, levels of the adhesion molecule sP-selectin are higher before 
and after exercise and have greater increases in response to exercise. This could have 






Heart failure (HF) is an increasingly prevalent, chronic, progressive, and incurable 
medical condition that is a major cause of morbidity and mortality (1-3). Although traditional 
medical risk factors in HF have been identified (4, 5) recent reviews suggest a role for 
depressive symptoms in the development and progression of HF (6, 7). Depressive 
symptomatology varies between 51% in hospitalized HF patients and 69% in recently 
discharged HF patients (7). Prospective studies indicate that higher levels of depressive 
symptoms as measured by the Beck Depression Inventory (BDI) in HF patients are 
independently associated with higher mortality within 3 years (7-9). However, little is known 
about pathophysiologic mechanisms underlying the increase in adverse outcomes in HF 
patients with depressive symptoms. 
Physical activity may play an important role in the sudden onset of adverse events such 
as acute coronary syndromes (ACS). Physical exertion occurring within 1-2 hours of onset of 
symptoms has been identified as a potent trigger of acute myocardial infarction (MI) in 
patients with coronary artery disease (CAD) (10-12). The underlying mechanisms, however, 
are still unclear. Recent studies suggest that adhesion molecules might be involved in 
mediating exercise-induced ACS triggering in vulnerable persons. In CAD patients Kop et al. 
found that treadmill exercise provoked significant immediate responses in the soluble 
intercellular adhesion molecule-1 (sICAM-1), a membrane-bound adhesion molecule 
expressed on endothelial cells and leukocytes (13, 14). Moreover, in HF patients exercise 
induced profound increases in platelet activation markers such as soluble P-selectin (sP-
selectin), an adhesion molecule expressed on platelets and endothelial cells (15). Both, 
ICAM-1 and P-selectin are clinically important because they support increased adhesion and 
infiltration of leukocytes and platelets, in the myocardium in HF patients (14, 16-19). 
Particularly soluble P-selectin which is elevated in HF patients (20) seems to be an 
independent significant predictor of cardiovascular events in HF patients (21). Exercise-
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induced elevations in either or both of these adhesion molecules may therefore be important 
in the disease course of HF. 
Although sympathoadrenal hyperactivity and reactivity to mental and physical 
challenges have been suggested to be involved in pathophysiologic mechanisms linking 
depression and increased mortality in HF, the role of adhesion molecules and other 
inflammatory measures has received little attention (22, 23). Therefore, the objective of the 
present study was to investigate whether depressive symptoms as assessed by the BDI are 
associated with exercise-induced changes in adhesion molecule levels in patients with HF 
and healthy controls. Plasma levels of sP-selectin and s-ICAM-1 were measured immediately 
before and after, and 10 min after a moderate exercise task. We hypothesized that higher BDI 
levels would be associated with greater adhesion molecule increases following exercise in 




The study sample consisted of 38 male patients diagnosed with HF and 19 male 
individuals with no cardiovascular pathology except for elevated blood pressure as a control 
group. Patients were recruited from the San Diego Veterans Affairs Medical Center and the 
University of California, San Diego Medical Center Heart Failure Program as part of a larger 
study on the effects of depression on cellular adhesion and inflammation. We recruited the 
control non-HF individuals from the local community via various advertisements (e.g., 
newspapers, flyers, brochures, and websites) and word of mouth referrals. 
Inclusion criteria for all study participants included age between 30-85 years, 
hypertension < 180/110 mm Hg, and men of all ethnicities and races. Inclusion criteria for HF 
patients included NYHA classes II-IV, symptoms of HF for at least 3 months which have 
been optimally treated with beta-blockers, diuretics and ACE inhibitors, and systolic 
dysfunction defined by an ejection fraction ≤ 45% or diastolic dysfunction,. Left ventricular 
ejection fraction (LVEF) was assessed by echocardiography as part of the patient’s routine 
medical evaluation. To assess functional capacity, we used the six-minute walk-test (24). 
Exclusion criteria included recent myocardial infarction (1 month), recent stroke or 
significant cerebral neurological impairment, severe chronic obstructive pulmonary disease, 
inability to exercise and psychiatric illness other than depression and comorbid anxiety. 
Subjects were instructed to abstain from taking aspirin for 24 hours prior to the testing 
session. 
The protocol was approved by the UCSD Institutional Review Board, and participants 
gave written informed consent. The study was carried out in accordance with the Declaration 
of Helsinki principles. 
 
Study protocol  
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Depressive symptom severity                                                                                                                                                    
On the morning of testing depressive symptom severity was assessed with the 21-item 
Beck Depression Inventory (BDI) where scores  ≥ 10 indicate possible clinical depression 
(25).  The BDI was developed for the assessment of depressive symptoms that correspond to 
the Diagnostic and Statistical Manual of Mental Disorders–IV (DSM-IV) criteria for major 
depressive disorder and measures a somatic and a cognitive-affective dimension of depression 
(26). The BDI assesses symptoms related to sadness, feelings of guilt, perceptions of self-
worth, suicidal ideation, and changes in appetite and body weight, among other 
characteristics. Subjects with scores ≥ 10 on the BDI were administered a modified 
Structured Clinical Interview for DSM-IV (SCID) (27) to evaluate for possible major 
depressive disorder (MDD). If suspected of having MDD they were presented with a list of 
options and referred to their treating physician. 
 
Exercise testing 
The exercise testing sessions commenced at approximately 11:30 am and lasted for 
1.5 hours. Participants abstained from food and drink (other than water) for two hours before 
the experiment, and from physical exercise, alcohol and caffeinated beverages starting the 
evening before the test day.  
Subjects performed a mild graded exercise task on a stationary bicycle (Viasprint 
150p, Viasys, Yorba Linda, CA).  Following a 5-10-min quiet rest, resting BP was taken 
using an automated BP monitor (Dinamap Compact BP® monitor, Critikon, Tempa, FL) and 
venous blood was taken via an intravenous catheter that was placed in the antecubital vein 
3hours prior.  Subjects began peddling on the bicycle and continued at the pace of their 
choice (e.g., 60bpm).  The bicycle protocol consisted of a 5 minute warm-up, 10 min steady 
state, and 2 min cool-down period. In order to apply the similar exercise intensity in relative 
to existing fitness levels for all participants, Borg’s ratings of perceived exertion (RPE) scale 
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(28) was used; the resistance (watts) of the bicycle was gradually increased during the warm-
up period to reach the rating of 12-13 (“somewhat hard”) and this perceived exertion level 
was maintained for the 10-min steady state exercise by adjusting the resistance and speed of 
cycling.  Based on our previous experience (29, 30), RPE of 12-13 consistently corresponds 
to 65-70% of VO2peak regardless of fitness levels.  Blood pressure, heart rate, and oxygen 
saturation levels (via a finger probe) were monitored throughout the bicycle exercise every 2 
minutes. Blood samples were obtained prior to, immediately following, and 10 minutes post-
exercise. Exercise was terminated if a subject expressed discomfort, excessive muscle fatigue, 
chest pain, shortness of breath, or if blood pressure exceeded 220/100 mmHg or dropped 
below resting levels.   
 
Biochemical analyses 
Blood was drawn into EDTA-coated vacutainer tubes (BD Biosciences, San Jose, CA, 
USA) for soluble adhesion molecules and catecholamines. Blood samples were centrifuged 
for 10min at 3,000g and 4°C and plasma was stored at –80°C until analysis.  
Circulating levels of soluble sP-selectin and sICAM-1 were determined following 
previous methods using enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, 
Mpls., MN) (31, 32). The precision and sensitivity performance values were: sICAM-1, 
intra-assay CV is 4.6%, inter-assay CV is 6.6, sensitivity is <0.35 ng/ml; sP-selectin intra-
assay CV is 5.1%, inter-assay CV is 8.8, sensitivity is <0.5 ng/ml. 
To minimize intra-assay error variance, all samples from an individual subject were 
analyzed in the same run. 
 
Statistical Analyses 
All calculations were performed using SPSS Inc. (version 11.0.1) software packages 
(SPSS, Chicago, IL). Data are presented as mean ± SEM. Results were considered 
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statistically significant at the p≤ .05 level and all tests were two-tailed. In both groups, 
normal distribution of data was verified prior to statistical analyses using the Kolmogorov-
Smirnov test. In case of missing data, cases were excluded listwise. We calculated mean 
arterial pressure (MAP) from resting BP readings (1/3 systolic BP + 2/3 diastolic BP) and 
body mass index (BMI) was calculated by the formula: weight in kg / (height in m)2. 
Power analyses suggest that a  total sample size of N = 44 is needed to detect an 
interaction effect between depressive symptom severity (as measured by BDI) and adhesion 
molecule changes following exercise (as measured by repeated measurement of adhesion 
molecules, pre, post, and 10-min recovery) in two groups with an expected medium effect 
size of f = 0.25 in general linear models with repeated measures with a power of  ≥ 0.95, α = 
0.05, given the observed intercorrelation among repeated measures of 0.5 (33).  
To test for group differences in sociodemographic and medical characteristics we 
computed univariate analyses of variance (ANOVA, Table 1). To test for associations 
between BDI scores and group characteristics, we calculated Pearson’s product-moment 
correlations for continuous variables and Spearman’s rank correlations for ordinal data.  
In subsequent analyses, we controlled for the cardiovascular risk factors age, BMI, 
MAP, and smoked cigarettes per day. We applied the Huynh-Feldt correction for all repeated 
measures.  
General linear models with repeated measures were calculated to test whether 
exercise induced significant changes over time in soluble adhesion molecule levels in HF 
patients and controls with subject group as independent and repeated measures of adhesion 
molecule levels as dependent variables (Table 2).  
Associations with depressive symptom severity. For independent associations between 
depressive symptom severity and adhesion molecules we applied the following procedure. To 
address associations at rest, we calculated linear regression analyses with pre-exercise 
measures of adhesion molecules as dependent variables and BDI scores as continuous 
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independent variable while controlling for the group variable (HF vs. controls). To address 
associations between depressive symptom severity and adhesion molecule changes over time 
in response to exercise we calculated general linear models with repeated measures of 
adhesion molecules as dependent variables. We entered BDI score as independent continuous 
variable while controlling for the group variable and pre-exercise adhesion molecule levels.  
To address whether associations between depressive symptom severity and adhesion 
molecules differ between HF patients and controls, we calculated moderator analyses as 
described by Baron & Kenny both, for resting adhesion molecule levels and for repeated 
adhesion molecule measures. We recalculated the above described regression analyses and 
general linear models and additionally entered the interaction between group and BDI score 
as independent variable (34, 35). In case of significant moderator effects of depressive 
symptoms we recalculated the analyses of the respective parameter separate for each group 
as post-hoc test. In HF patients, we additionally controlled for LVEF and NYHA class to test 
whether the observed associations are mediated by HF severity, and for current diabetes 
mellitus.  
In calculations on associations with depressive symptom severity, all included 
parameters were Z-transformed prior to analyses rendering a mean of 0 and a standard 
deviation of 1 to allow computation of interaction terms.  
To graphically illustrate our continuously calculated significant findings we 
categorized the study groups based on their BDI score into four groups of subjects with either 
high or low BDI score (HF-BDI-high (≥ 8, n=21), HF-BDI-low (< 8, n=17), controls-BDI-





Sociodemographic and medical characteristics of the study groups 
Table 1 presents the biological and medical characteristics of the 38 HF patients and 
the 19 controls studied. Most of the patients were NYHA class II and were taking ACE 
inhibitors, beta-blockers, and diuretics, and a high percent of patients was taking digoxin. HF 
patients walked fewer meters in the six-minute walk test as compared to controls 
(F(1/54)=30.3, p<.001). Moreover, HF patients were older (F(1/54)=10.1, p=.002) and had a 
lower MAP (F(1/55)=10.7, p=.002) probably due to medication intake and/or their 
underlying LVEF dysfunction. HF patients had higher BDI total scores (F(1/56)=11.2, 
p=.001) as well as higher scores in the BDI subscale “somatic symptoms” (F(1/56)=26.5, 
p<.001). None of the study subjects were determined to have major depressive disorder. In 
both subject groups, BDI score was not significantly associated with cardiovascular risk 
factors (i.e. age, BMI, resting MAP). In HF patients, BDI score was not significantly 
associated with medication intake, or disease severity indices. None of the medications were 
associated with either adhesion molecule with the exception of digoxin correlating with s-
ICAM (r=-.34, p=.043). 
 
Reactivity of adhesion molecules to exercise 
Table 2 depicts adhesion molecule baseline and post exercise levels in HF patients 
and controls. HF patients showed higher s-ICAM levels before and after exercise (main 
effect group: F(1/51)=6.5, p=.014, η2=.11). However, no other main or interaction effects 
were significant, neither for s-ICAM (p’s>.38) or for sP-selectin (p’s>.24). Cardiovascular 
risk factors (age, BMI, MAP, and smoking) were controlled. 
 
Depressive symptom severity and adhesion molecules 
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As aforementioned, we first tested whether depressive symptom severity is associated 
with adhesion molecules in both groups (i.e. independent of groups). Second, we investigated 
whether associations between depressive symptom severity and adhesion molecules differ 
between HF patients and controls by means of moderator analysis. Cardiovascular risk 
factors (age, BMI, MAP, and smoking) were controlled in all analyses.  
At rest. Regression analyses revealed that independent of groups (HF vs. controls) 
BDI scores were not significantly associated with pre-exercise levels of sP-selectin (β=-.05, 
p=.76) or s-ICAM (β=-.07, p=.63) (Figure 1). There was no moderation effect of depressive 
symptom severity on group differences in pre-exercise adhesion molecule levels (p’s>.23).  
Reactivity to exercise. To test whether depressive symptom severity is independently 
(i.e. independent of groups and cardiovascular risk factors) associated with adhesion 
molecule changes over time in response to exercise we calculated general linear models with 
adhesion molecule measures as repeated dependent variables and BDI score as continuous 
independent variable while controlling for pre-exercise adhesion molecule levels and groups 
(HF vs. controls). Higher BDI scores were significantly associated with greater increases in 




=.08, f=.29). Moreover, higher BDI was associated with higher 
sP-selectin levels at pre and post-exercise time points (main effect for BDI: F(1/53)=4.3, 
p=.043, ηp2=.08, f=.28), but this effect became of borderline significance when controlling 
for cardiovascular risk factors (p=.07).  However, there was no association between BDI and 
s-ICAM-1 exercise reactivity (p’s>.31).  
Moderation testing revealed that the interaction between group and BDI scores was 




=.06, f=.26) but not in s-ICAM-1 (p=.21). This suggests a 
statistical moderation effect of depressive symptoms: as depicted in Figure 1 higher 
depressive symptom scores are associated with higher exercise-induced sP-selectin increases 
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in the HF group as compared to the control group. Post-hoc testing of this significant 
moderation effect revealed that in HF patients higher BDI scores were significantly 
associated with greater increases in sP-selectin levels over time in response to exercise 
(interaction BDI-by-exercise: F(1.6/49.6)=5.67, p=.010, ηp2=.16, f=.43), even after 
controlling for LVEF and NYHA class as indicators of HF severity (p=.018) and diabetes 
mellitus (p=.01). Also, higher BDI scores were associated with higher sP-selectin levels at pre 
and post-exercise time points (main effect BDI: F(1/31)=4.86, p=.035, ηp2=.14, f=.40). This 
association remained significant after controlling for diabetes mellitus (p=.47) but became of 
borderline significance when controlling for LVEF and NYHA class (p=.059). None of these 
associations was observed in controls (p’s>.83). Noteworthy, LVEF (main effect LVEF: 
F(1/29)=5.36, p=.028, ηp2=.16, f=.43); interaction LVEF-by-exercise: F(1.8/51.8)=4.41, 
p=.020, ηp2=.13, f=.39), but not NYHA (p’s>.86) or diabetes mellitus status (p’s>.51) were 




This is the first study to investigate whether in male HF patients and healthy controls, 
depressive symptoms are associated with exercise-induced increases in circulating levels of 
adhesion molecules expressed on endothelial cells and leukocytes (ICAM-1) as well as on 
endothelial cells and platelets (P-selectin). Our main finding was that in HF patients but not 
in controls higher depressive symptom scores were associated with higher sP-selectin 
increases in response to exercise over time peaking immediately after exercise cessation. 
Moreover, higher levels of depressive symptoms were associated with higher sP-selectin 
levels at all time points in our HF patients but not in controls. These associations were of 
large effect sizes and independent of both cardiovascular risk factors, indicators of HF 
severity, and diabetes mellitus status. In other words, in HF patients with increasing 
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depressive symptom severity, sP-selectin levels are not only on a generally higher level 
before and after exercise but also increased more strongly in reaction to a moderate bicycle 
exercise. Noteworthy, both BDI subscales (i.e. somatic symptoms and cognitive/affective 
symptoms) similarly contributed to the observed associations (see supplement 3). In contrast, 
there were no associations between depressive symptoms and s-ICAM-1 levels, either at rest 
nor in response to exercise.  
Our findings indicate a diverging pattern between depressive symptoms and the two 
measured soluble adhesion molecules in HF patients suggesting a role for platelet activation. 
sP-selectin but not s-ICAM-1 relates to platelet activation. P-selectin is constituitively 
expressed both in the α-granules of platelets and the Weibel-Palade bodies of endothelial 
cells, with a soluble form present in the plasma (36, 37). It plays a crucial role in thrombus 
formation interconnecting inflammatory, thrombotic and coagulation activity (36). More 
precisely, P-selectin translocates to the surface of activated platelets incorporated into a 
growing thrombus and supports recruitment of circulating leukocytes. It induces expression 
of tissue factor (TF) on monocytes and mediates binding of platelets to monocytes and 
neutrophils. As TF binds coagulation factor VII and activates coagulation factors IX and X, 
P-selectin-induced TF synthesis on monocytes seems to support and maintain the local 
activation of blood coagulation in the hours following monocyte recruitment (36). Following 
expression on the platelet surface P-selectin is rapidly shed. This shedding from platelets is 
suggested to be the main source of the soluble form found in plasma following thrombotic 
events (38, 39). However, although the P-selectin translocated on activated endothelial cells 
is recycled back into the cell, part of the soluble P-selectin found in plasma may be of 
endothelial origin (36, 40). Noteworthy, markers of platelet activity other than sP-selectin 
have also been positively associated with HF and HF severity (41). ICAM-1 is expressed by 
several cell types including leukocytes and endothelial cells (14), but to the best of our 
knowledge not by platelets. In vitro studies using cultured endothelial cells established that 
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sICAM-1 simply reflects ICAM-1 expression on these cells (42). Thus, in HF patients 
depressive symptoms may be associated with higher platelet but not endothelial activity 
before and after as well as in reaction to exercise.  
We observed strong associations between depressive symptoms and higher levels of 
the measured soluble adhesion molecules in HF patients but not in controls. Moreover, low 
LVEF (as an indicator of HF severity) was significantly associated with repeated sP-selectin 
levels. Thus, our results suggest that associations between depressive symptoms and higher 
sP-selectin levels following exercise seem to be specific to HF patients but not controls. 
Noteworthy, depressive symptom severity was significantly lower in controls as compared to 
HF patients. Therefore, we can not completely rule out that in a non-HF control group with 
higher levels of depressive symptoms there might be associations with sP-selectin levels 
following exercise. Such reasoning is in line with the reported significant associations 
between BDI scores and repeated sP-selectin levels independent of groups (i.e. main effect of 
BDI and interaction BDI-by-exercise). However, it is possible that the latter associations 
became significant because of the strong associations within the HF group. 
The finding on higher platelet activity following exercise in HF patients is in line with 
a recent study reporting increases in several platelet activation markers including sP-selectin 
in HF patients following exercise (15). Noteworthy, this study used a maximum treadmill 
graded exercise inducing sP-selectin increases in all patients whereas we used a moderate 
exercise testing, inducing increases only in patients with higher levels of depressive 
symptoms. It is interesting that the depression effect we observed was evident in response to 
our moderate exercise challenge - one that was not challenging enough to induce a sP-
selectin increase in HF patients with little or no depression or controls but only in those HF 
patients with greater depressive symptoms.  
Our findings may have clinical implications, since both platelet-derived and 
endothelial-derived P-selectin play important roles in different phases of atherosclerosis. In 
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addition to its role in thrombus formation and coagulation, platelet-expressed P-selectin may 
affect later phases of atherosclerosis via the generation of circulating pro-inflammatory 
platelet-leukocyte aggregates. These aggregates seem to promote plaque progression and 
increased levels of these aggregates have been found in stable and acute coronary syndromes 
(43, 44). Endothelial-derived P-selectin supports leukocyte tethering and rolling which is 
required for the firm adhesion/activation and transmigration of leukocytes, a critical step in 
the early phase of the atherosclerotic process (45-47). Changes in platelet activity play an 
important role in patients with coronary artery disease (CAD) since thrombus formation has 
been shown to be the major cause of ACS in these patients (41, 48). The precise role of 
increased platelet activation in patients with HF, however, is less apparent. It appears to be 
part of the shift towards a pro-inflammatory state that is characteristic of heart failure (41, 49, 
50). In this setting, increases in platelet activity would be expected to predispose patients to a 
thrombotic state. The resultant increase in pulmonary and systemic emboli and myocardial 
ischemia (particular in HF patients with underlying CAD) would adversely affect morbidity 
and mortality in this population. Given the atherogenic properties of sP-selectin and given 
that physical exertion  is suggested to play an important role in the onset of ACS (10-12) our 
results might suggest a mechanism underlying the association between depressive symptom 
severity and heightened mortality in HF patients. HF patients with higher levels of depressive 
symptoms may be particularly susceptible to exercise-induced triggering of ACS because of 
heightened sP-selectin expression and thereby platetet activation in response to moderate 
exercise. In line with such reasoning, a recent study by Strike et al. similarly suggests a role 
for heightened platelet activity in mediating ACS triggering (51). In that study, ACS 
survivors who had experienced emotional but not exercise-induced ACS triggering in the 2 
hours before symptom onset showed elevated proportions of platelet-leukocyte, -monocyte, 
and – neutrophil aggregates in reaction to psychological stressors. As mentioned earlier, 
these aggregates can be promoted by sP-selectin. Also, although sP-selectin levels had 
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returned to near resting levels within 10 minutes of exercise cessation, it is likely that the 
effects on platelet aggregate formation and subsequent platelet proinflammatory activity 
continue for at least 30 minutes (36, 51). Given that a moderate exercise as used in our study 
might be comparable to the physical activity a patient may perform in daily life and given the 
known ACS triggering effect of physical exertion our findings might be of clinical 
importance. 
The molecular mechanisms leading to higher sP-selectin responses to exercise with 
depressive symptom severity in HF remain to be investigated. Although epinephrine is known 
to activate platelet activity (37) and although norepinephrine has been suggested to mediate 
mental stress-induced increases in platelet P-selectin in depressive caregivers (52) our data 
indicate that the observed associations in our study were neither mediated nor moderated by 
catecholamine secretion (see supplement 1). This non-significant finding could relate to the 
fact that almost all of our patients were using beta-blockers. Although beyond the scope of 
the present study, a speculative explanation for the observed associations between sP-selectin 
reactivity to exercise and depressive symptom severity in our HF patients may relate to 
genetic differences as a functional polymorphism in the promoter region of the serotonin 
transporter gene (5HTTLPR) has been associated with platelet activation in depression. Other 
potential explanations include activation of pro-inflammatory mechanisms and metabolic 
dysregulation which are known to increase proclivity to platelet activation and thrombotic 
events (37, 41). 
Strengths and limitations of our study are discussed in supplement 3. 
In conclusion, our findings suggest that with increasing depressive symptom severity, 
levels of the adhesion molecule sP-selectin are not only higher before and after exercise but 
also showed greater exercise-induced increases in male HF patients as compared to controls. 
Future research would benefit from including more measures of platelet activity and address 
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whether our findings have implications for ACS following exercise and thereby mortality in 
HF patients with higher levels of depressive symptoms. 
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Table 1. Sociodemographic and Medical Characteristics of the Study Subjects  
 HF patients controls p 
BDI score 10.2 ± 1.0 (0-26) 4.6 ± 1.3 (0-21) .001 
BDI score ≥ 10 47.4 % 10.5 %  
BDI subscale “somatic symptoms” score 5.7 ± 0.4 (0-11) 2.1 ± 0.5 (0-7) <.001 
BDI subscale “cognitive/affective 
symptoms” score 
4.5 ± 0.7 (0-16) 2.6 ± 0.9 (0-14) .10 
Age [years] 59.4 ± 2.4 (31-81) 47.8 ± 2.1 (35-76) .002 
Body mass index [kg/m2] 30.5 ± 1.2 (20.4-51.2) 29.0 ± .8 (23.7-37.7) .41 
Mean arterial blood pressure [mmHg] 80.8 ± 2.3 (56.7-124.2) 93.6 ± 3.1 (74.2-116.7) .002 
Cigarettes per day 4.1 ± 2.0 (0-60) 2.2 ± 1.4 (0-20) .50 
Current smokers  13 % 16 %  
CHF severity    
    6-minute walk test [meter] 362.3 ± 14.9 (170-624) 500.6 ± 19.8 (350-690) <.001 
     Ejection fraction [%] 30.1 ± 1.5 (14-54) -  
 1 
    NYHA classification II  89 % 0 %  
    NYHA classification III  11 % 0 %  
Concomitant disease    
    Diabetes mellitus  26 % 0 %  
Medication     
    ACE-blocking agents 84 %  0 %  
    Beta blockers  95 % 0 %  
    CCB  3 % 0 %  
    Statin  61 % 0 %  
    Aspirin  50 % 5 %  
   Diuretics  84 % 0 %  
   Anti-arrhythmics  18 % 0 %  
   Warfarin 39 % 0 %  
   Digoxin  61 % 0 %  
Data are presented as mean ± standard error of means (range) or percentage value, BDI: Beck Depression Inventory, CCB: Calcium channel 
blockers 
 0 
Table 2.  Soluble Adhesion Molecule Levels before and after Exercise in HF 
Patients and Controls 
 
   Pre-exercise   Post-exercise        Recovery 
sP-selectin [pg/ml]    
       HF patients 55.8 ± 4.6 62.3 ± 6.4 53.1 ± 4.1 
       controls 62.0 ± 6.9 53.9 ± 9.6 51.8 ± 6.1 
sICAM-1 [ng/ml]    
       HF patients 322.6 ± 16.9 329.1 ± 17.1 322.6 ± 16.0 
       controls 243.9 ± 25.5 239.5 ± 25.6 247.9 ± 24.1 
Values are means ± SEM; pre-exercise: immediately before exercise; post-exercise: 







Legend to Figure 1 
Values are means±SEM. The figure depicts exercise-induced changes in sP-selectin in 
HF patients and controls with high (≥8) and low (<8) Beck Depression Inventory (BDI) 
scores. Moderation testing suggests that in the HF group higher depressive symptom scores 
are associated with higher exercise-induced sP-selectin increases as compared to the control 
group (F(1.8/84.5) = 3.25, p = .05, η
 p
 2
 = .06, f = .26). In HF patients but not in controls 
higher BDI scores were significantly associated with higher sP-selectin levels at pre and post-
exercise time points (main effect BDI: F(1/31) = 4.86, p = .035, η
 p
 2
 = .14, f = .40) and with 
greater exercise-induced sP-selectin increases (interaction BDI-by-exercise: F(1.6/49.6) = 
5.67, p = .010, η
 p
 2
 = .16, f = .43).  The area shaded in grey marked as “exercise” includes 
warm-up, 10-min steady state cycling, and 2-min cool-down periods. 
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